<DOC>
	<DOCNO>NCT01558362</DOCNO>
	<brief_summary>The need exist alternative 99mTc base perfusion radiotracers cardiac patient management . An alternative radiotracer , I123-CMICE-013 , develop Canadian Molecular Imaging Center Excellence ( C-MICE ) University Ottawa Heart Institute . Initial test result rat pig suggest addition cyclotron-produced alternative 99mTc tracer , I-123-CMICE-013 may superior tracer measure myocardial perfusion.This Phase 1 study study safety tolerability , biodistribution , pharmacokinetics radiation dosimetry , distribution localization I123-CMICE-013in healthy adult volunteer .</brief_summary>
	<brief_title>A Study 123I-CMICE-013 Radiopharmaceutical Healthy Volunteers</brief_title>
	<detailed_description>Single photon emission compute tomography ( SPECT ) myocardial perfusion imaging ( MPI ) establish , cost effective tool risk stratification management patient suspect known coronary artery disease ( CAD ) Myocardial perfusion image significantly affect interruption supply 99mMo , parent isotope 99mTc use majority MPI . An alternative radiotracer , I123-CMICE-013 , develop Canadian Molecular Imaging Center Excellence ( C-MICE ) University Ottawa Heart Institute , complete pre-clinical trial test ready Phase 1 human trial . This Phase I study single centre , open label study . Subjects receive 2 dos study drug . One rest dose one stress dose administer separate day , one week apart . Subjects undergo standard clinical exercise stress protocol stress dose . Gamma camera image follow administration do 2 day . Biodistribution , pharmacokinetics , dosimetry safety variable analyze .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Radiopharmaceuticals</mesh_term>
	<criteria>1 . Age 18 65 year 2 . No significant medical history 3 . Normal physical exam 4 . BMI â‰¤ 30 kg/m2 5 . No current use prescription medication 6 . No clinically significant abnormality baseline laboratory work 7 . No clinically significant abnormality baseline 12 lead electrocardiogram 8 . Female subject must postmenopausal , surgically sterilize negative urine beta human chorionic gonadotropin pregnancy test initial screen 1 . Pregnancy 2 . Known hypersensitivity investigational drug component 3 . Claustrophobia inability lie still supine position 4 . Unwillingness provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>myocardial perfusion imaging</keyword>
	<keyword>single photon emission tomography</keyword>
	<keyword>Coronary artery disease</keyword>
	<keyword>gamma camera imaging</keyword>
	<keyword>Phase 1 clinical trial</keyword>
	<keyword>cyclotron</keyword>
</DOC>